• Approved for used in radiotherapy only.

• Due to the SLS content to be used as a soap substitute only.

• Hydromol® Ointment is made to the same formula and is more cost effective.

• This product is also known locally as ‘Emulsifying Ointment RVI
  Formula’. It is softer than emulsifying ointment BP. Epaderm ointment is
  made to the same formula, but is more expensive.

• Approved for used in radiotherapy only.

• SLS free alternative to Aqueous Cream.

• Alternative to Diprobase

• Alternative to E45® Cream.

• Alternative to Doublebase gel.

• Alternative to Aveeno

• Alternative to Oilatum®.

• Alternative to Balneum®.

• 2g, 28g & 92g barrier cream, 28ml pump spray, sterile 1ml no
  sting barrier film foam applicator, sterile 3ml no sting
  barrier film foam applicator

• For limited use around gastrostomies when wound breakdown is thought to be aggravated by leakage of gastric acid.

- available as Dermacool

• Scalp application

• Ointment

MODERATELY POTENT

• Cream and ointment

POTENT

• Cream, ointment & scalp application

POTENT

• Cream and ointment

POTENT

POTENT

Cream and ointment

VERY POTENT
Cream, ointment & scalp application

VERY POTENT

Ointment

MODERATELY POTENT

Cream, ointment & scalp application

MODERATELY POTENT

POTENT
Cream, ointment & gel

MILD

• Cream

MILD
Cream and ointment

MILD

MILD

• Cream and ointment

MILD

POTENT

MILD

• Cream and ointment

MILD

• Cream

MODERATELY POTENT

• Containing clobetasone 0.5%, oxytetracycline3% and nystatin 100,000units/g  unlicensed
• If no licensed alternative is suitable, Trimovate is available as an imported medicine via Alliance Healthcare Distribution. In order for community pharmacies to be able to dispense this ULM, it must be prescribed generically as 'Clobetasone 0.05%/ Oxytetracycline 3%/ Nystatin 100,000 units/g cream (Special Order)'. Please note this will be at a significantly higher cost than the licensed version and will be subject to handling charges.
• Further information can be found on the PSNC website.

• Approved for adults with severe chronic hand eczema that have not responded to potent topical corticosteroids in line with NICE.

• Cream containing coal tar extract 5%, hydrocortisone 0.5% and allantoin 2%

• 0.005% Cream and ointment
• 0.005% scalp application
  
  

• Gel and ointment (Dovobet®)
  
  • approved for the treatment of scalp and mild to moderate non scalp plaque psoriasis vulgaris in adults.
  
  
• 60g cutaneous spray (Enstilar®)
  
  • Approved for the treatment of plaque psoriasis 
  
  

• 1% unlicensed
• 2% unlicensed
• 5% unlicensed

• 0.05%/3%

• 0.1%, 0.25%,0.5%,1%, & 2% 

• 0.2%, 0.4% & 0.6% unlicensed

• 0.1%, 0.2%, 0.4%, 0.6%, 0.8%, 1%, 2%, 4%, 6% & 8%.

• 0.1%, 0.2%, 0.4%, 0.6%, 0.8%, 1%, 2%, 4%, 6%, 8% & 16%in emulsifying base.

• 2%, 5%, 10% and 20%.

• 10mg and 25mg capsules 

• 30mg & 120mg tablets

• Approved for psoriasis in line with NICE.
• Approved for the treatment of moderate to severe hidradenitis suppurativa in line with NICE and NHS England Commissioning Policy
• Approved for the treatment of plaque psoriasis in children and young people in line with NICE

• 10mg, 20mg & 30mg tablets
• To be used in accordance with NICE guidance

• 210mg/1.5ml solution for injection in pre-filled syringes.
• Approved for the treatment of moderate to severe plaque psoriasis in line with NICE 

• Capsules & SF Solution 
  See section 8.2.2

• 120mg tablets
• Approved for the treatment of moderate to severe plaque psoriasis in line with NICE

• Approved for psoriasis in line with NICE
• Approved for the treatment of plaque psoriasis in children and young people in line with NICE

• 100mg/1mL solution for injection
• Approved for the treatment of moderate to severe plaque psoriasis in line with NICE

• Approved for psoriasis in line with NICE.

• Approved for the treatment of moderate to severe plaque psoriasis in adults in line with NICE

• See section 08.01.03

• Approved for moderate disease on face and neck for those between 2 and 16 years in line NICE.

• Approved for the treatment of plaque psoriasis in line with NICE.

• Approved for moderate to severe disease atopic eczema in patients over 2 years in line with NICE.

• 45mg & 90mg SC injections approved for psoriasis and psoriatic arthritis in line with NICE.
• Approved for the treatment of plaque psoriasis in children and young people in line with NICE

• 15% (Finacea®) and 20% (Skinoren®) gel 

• 1% topical solution (alcohol – water basis)
• 1% lotion (aqueous)

• For specialist initiation for the treatment of severe rosacea. Following specialist review of effectiveness, primary care can continue supply.

• For the treatment of papulopustular rosacea in patients as second line treatment in patient who have failed topical metronidazole.

• Tablets containing cyproterone acetate 2mg & ethinylestradiol 35 micrograms.
• Note: generic co-cyprindiol is much cheaper than Dianette®

• Tablets containing cyproterone acetate 2mg & ethinylestradiol 35 micrograms
  – generic co-cyprindiol is much cheaper than Dianette®

• 5mg, 10mg, 20mg & 40mg capsules
• Isotretinoin is a toxic drug only to be prescribed by or under the supervision of a consultant dermatologist – see BNF and product literature.

See section 13.5.2

In flexible collodion

• 6 inch applicator
• 95% pencils
• 0.5% solution 

• 10%, 75% & 90% solution.

• Second line specialist use for treatment of ano-genital warts (mainly in genitourinary medicine [GUM] clinics).

• For the treatment of superficial malignant and premalignant skin lesions. To be initiated with advice of specialists.

• 150 micrograms/g & 500 micrograms/g gel 
• For the treatment non-hyperkeratotic, non-hypertrophic actinic keratosis
  in adults

• Shampoo containing a mixture of tar preparations & 0.3% Cade oil

• Tablets containing cyproterone acetate 2mg & ethinylestradiol 35 micrograms.
• Note: generic co-cyprindiol is much cheaper than Dianette®

• Approved for use as a second-line treatment of facial hirsutism in patients where co-cyprindiol is ineffective, contra-indicated or considered inappropriate. Treatment should be initiated by or on the specific advice of an appropriate specialist - endocrinologist (or gynaecologist).

• For limited use in burns/plastic surgery patients only.

Cream, ointment & gel

Cream & gel

• 2% cream
• shampoo

• For use in ENT surgery & epistaxis
  1.25cm x 100cm & 2.5cm x 100cm impregnated gauze
  

• 2.5% castor oil & colophony 2.5% in a collodion base.

• 2ml, 4ml & 10ml prefilled syringe.
• For use in plastic surgery to close dead spaces, adhere skin graft, close simple wounds and stabilise bone grafts.

• For use in neurosurgery and vascular surgery.

2ml and 5ml kit

• 2ml, 4ml & 10ml kit
• Also approved for use in the treatment of mesh fixation in hernia repair.

• 4.8 & 9.5 cm 2 Haemostatic (collagen sponge coated with fibrinogen and thrombin) - for use in liver and renal surgery.

Containing 70% isopropyl alcohol or methylated spirit (e.g. Clini-wipes®, Alcowipes®)

70% liquid & 70% spray

• Sterile solution – bottles
• 25ml & 100ml sachets(Normasol®)
• 45ml plastic ampoules/pods (Miniversol®)

• 1% chlorhexidine acetate dusting powder.

• 0.02% & 0.05% solutions, 25ml & 100ml sachets 
• 0.5% solution in 70% methylated spirit (pink, colourless & red staining)
• 2.5% in 70% methylated spirit wipes
• 0.5% hand rub (contains 70% isopropyl alcohol + emollients)
• 4% surgical scrub
• 2% in 70% isopropyl alcohol wipes (Sanicloth® & Clinell®)
• Skin swabs & skin cleanser
• 3ml & 10.5ml applicators (Chloraprep®)
• 1% Obstetric cream

• Solution containing Betaine 0.1% (surfactant) and Polyhexanide 0.1% (a chlorhexidine polymer). Mainly for use from 40ml plastic ampoules.
  Also available as a gel. 
• To be prescribed/used only on the advice of tissue viability specialists.

• Secondary care use only

• Used in some trusts as an alternative to chlorhexidine scrub and Triclosan skin cleanser in MRSA prophylaxis/eradication.

• 2.5% dry powder spray
• 10% alcoholic solution
• 7.5% surgical scrub
• 10% antiseptic solution (aqueous)
• 0.35% sterile aqueous solution 
  
  • approved for use in the prevention of surgical site infection in arthroplasty. 
  
  

• 1% sterilising solution.

• 1% or 2% skin cleanser
• 0.5% hand rub

• 10 volume (3%) & 20 volume (6%) solutions.

• 400mg solution tablets
• 5% solution unlicensed - under review

• For limited use in some operating theatres only.

• For limited use in some operating theatres/critical care areas only.

Paint containing magenta 0.4%, boric acid 0.8%, phenol 0.004%, resorcinol 8%, acetone and alcohol (or industrial methylated spirit).

• Used for the management of sloughy wounds.

• Aluminium chloride hexahydrate 20% solution in an alcoholic basis

• 100 unit vials for injection (Botox) – see section 4.9.3

• For limited use as an alternative to surgery in some patients.

•  To be initiated by specialist.